[1] 孙可欣,郑荣寿,曾红梅,等.2014年中国肺癌发病和死亡分析[J].中华肿瘤杂志,2018,40(11):805-811.
[2] 宋冠初,郭根燕,陆永涛,等.110例局部非小细胞肺癌手术治疗的预后分析[J].现代肿瘤医学,2020,28(10):1659-1663.
[3] 景子涵,车德海,于雁.ⅢA(N2)期非小细胞肺癌术后不良预后影响因素及术后辅助治疗的研究进展[J].癌症进展,2019,17(7):22-26.
[4] MIGLIORE M, CRISCIONE A, CALVO D, et al. Safety of video-assisted thoracic surgery lobectomy for non-small-cell lung cancer in a low-volume unit[J].Future Oncol,2016,12(23s):47-50.
[5] 王腾飞,耿玉六,陈浩, 等.完全胸腔镜下肺癌根治术治疗非小细胞肺癌手术相关指标及安全性观察[J].贵州医药,2019,43(1):84-86.
[6] 胡青,杨洋,林永德, 等.完全胸腔镜单操作孔法行肺叶切除术在非小细胞肺癌中的应用效果[J].广西医科大学学报,2019,36(2):270-273.
[7] BERRY M F, D'AMICO T A, ONAITIS M W, et al. Thoracoscopic approach to lobectomy for lung cancer does not compromise oncologic efficacy[J].Ann Thorac Surg,2014,98(1):197-202.
[8] YANG C F, MEYERHOFF R R, MAYNE N R, et al. Long-term survival following open versus thoracoscopic lobectomy after preoperative chemotherapy for non-small cell lung cancer[J].Eur J Cardiothorac Surg,2016,49(6):1615-1623.
[9] QU Y, ZHAO G, LI H. Forward and Reverse Signaling Mediated by Transmembrane Tumor Necrosis Factor-Alpha and TNF Receptor 2: Potential Roles in an Immunosuppressive Tumor Microenvironment[J].Front Immunol,2017,8:1675.
[10] 梁皓,程远方,王江波, 等.胸腔镜与传统开放手术治疗非小细胞肺癌临床效果比较[J].中华医院感染学杂志,2018,28(17):2618-2620.
[11] 王俊钢,张洁,杨丽, 等.完全胸腔镜引导下的肺癌微创手术与传统开放手术术后感染发生情况比较[J].中华医院感染学杂志,2018,28(21):3265-3269. |
2021, Vol. 38 
